Please read this leaflet carefully before you use ONDANSETRON TABLETS VIATRIS. This leaflet answers some common questions about ONDANSETRON TABLETS VIATRIS. It does not contain all of the available ...
The company is also pursuing potential FDA approval for oncology support applications. The drug is a proprietary bimodal extended-release tablet formulation of ondansetron, a 5-HT3 antagonist that has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results